Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: vorinostat|DRUG: anastrozole|DRUG: letrozole|DRUG: exemestane|PROCEDURE: positron emission tomography|RADIATION: F-18 16 alpha-fluoroestradiol|RADIATION: fludeoxyglucose F 18|OTHER: laboratory biomarker analysis
Sponsor: University of Washington
Collaborators: National Cancer Institute (NCI)